Literature DB >> 18849643

Application of a global proteomic approach to archival precursor lesions: deleted in malignant brain tumors 1 and tissue transglutaminase 2 are upregulated in pancreatic cancer precursors.

Wang Cheung1, Marlene M Darfler, Hector Alvarez, Brian L Hood, Thomas P Conrads, Nils Habbe, David B Krizman, Jan Mollenhauer, Georg Feldmann, Anirban Maitra.   

Abstract

BACKGROUND: Pancreatic cancer is an almost uniformly fatal disease, and early detection is a critical determinant of improved survival. A variety of noninvasive precursor lesions of pancreatic adenocarcinoma have been identified, which provide a unique opportunity for intervention prior to onset of invasive cancer. Biomarker discovery in precursor lesions has been hampered by the ready availability of fresh specimens, and limited yields of proteins suitable for large scale screening.
METHODS: We utilized Liquid Tissue, a novel technique for protein extraction from archival formalin-fixed material, and mass spectrometry to conduct a global proteomic analysis of an intraductal papillary mucinous neoplasm (IPMN). Tissue microarrays comprised of 38 IPMNs were used for validation of candidate proteins.
RESULTS: The proteomic analysis of the IPMN Liquid Tissue lysate resulted in identification of 1,534 peptides corresponding to 523 unique proteins. A subset of 25 proteins was identified that had previously been reported as upregulated in pancreatic cancer. Immunohistochemical analysis for two of these, deleted in malignant brain tumors 1 (DMBT1) and tissue transglutaminase 2 (TGM2), confirmed their overexpression in IPMNs.
CONCLUSION: Global proteomics analysis using the Liquid Tissue workflow is a feasible approach for unbiased biomarker discovery in limited archival material, particularly applicable to precursor lesions of cancer. Copyright 2008 S. Karger AG, Basel and IAP.

Entities:  

Mesh:

Substances:

Year:  2008        PMID: 18849643      PMCID: PMC2711211          DOI: 10.1159/000161012

Source DB:  PubMed          Journal:  Pancreatology        ISSN: 1424-3903            Impact factor:   3.996


  57 in total

Review 1.  Phases of biomarker development for early detection of cancer.

Authors:  M S Pepe; R Etzioni; Z Feng; J D Potter; M L Thompson; M Thornquist; M Winget; Y Yasui
Journal:  J Natl Cancer Inst       Date:  2001-07-18       Impact factor: 13.506

Review 2.  Proteomics in early detection of cancer.

Authors:  P R Srinivas; S Srivastava; S Hanash; G L Wright
Journal:  Clin Chem       Date:  2001-10       Impact factor: 8.327

3.  Early detection cancer research network.

Authors:  S Srivastava; B S Kramer
Journal:  Lab Invest       Date:  2000-08       Impact factor: 5.662

4.  Identification of proteins from formalin-fixed paraffin-embedded cells by LC-MS/MS.

Authors:  David K Crockett; Zhaosheng Lin; Cecily P Vaughn; Megan S Lim; Kojo S J Elenitoba-Johnson
Journal:  Lab Invest       Date:  2005-11       Impact factor: 5.662

Review 5.  Molecular markers of early pancreatic cancer.

Authors:  Michael Goggins
Journal:  J Clin Oncol       Date:  2005-07-10       Impact factor: 44.544

6.  Effect of screening and adjuvant therapy on mortality from breast cancer.

Authors:  Donald A Berry; Kathleen A Cronin; Sylvia K Plevritis; Dennis G Fryback; Lauren Clarke; Marvin Zelen; Jeanne S Mandelblatt; Andrei Y Yakovlev; J Dik F Habbema; Eric J Feuer
Journal:  N Engl J Med       Date:  2005-10-27       Impact factor: 91.245

7.  Pathologic examination accurately predicts prognosis in mucinous cystic neoplasms of the pancreas.

Authors:  R E Wilentz; J Albores-Saavedra; M Zahurak; M A Talamini; C J Yeo; J L Cameron; R H Hruban
Journal:  Am J Surg Pathol       Date:  1999-11       Impact factor: 6.394

8.  Pancreatic cancer proteome: the proteins that underlie invasion, metastasis, and immunologic escape.

Authors:  Ru Chen; Eugene C Yi; Samuel Donohoe; Sheng Pan; Jimmy Eng; Kelly Cooke; David A Crispin; Zhaoli Lane; David R Goodlett; Mary P Bronner; Ruedi Aebersold; Teresa A Brentnall
Journal:  Gastroenterology       Date:  2005-10       Impact factor: 22.682

9.  Differentially expressed genes in pancreatic ductal adenocarcinomas identified through serial analysis of gene expression.

Authors:  Steven R Hustinx; Dengfeng Cao; Anirban Maitra; Norihiro Sato; Sean T Martin; D Sudhir; Christine Iacobuzio-Donahue; John L Cameron; Charles J Yeo; Scott E Kern; Michael Goggins; Jan Mollenhauer; Akhilesh Pandey; Ralph H Hruban
Journal:  Cancer Biol Ther       Date:  2004-12-14       Impact factor: 4.742

10.  Antigen retrieval for proteomic characterization of formalin-fixed and paraffin-embedded tissues.

Authors:  Haifeng Xu; Li Yang; Weijie Wang; Shan-Rong Shi; Cheng Liu; Ying Liu; Xueping Fang; Clive R Taylor; Cheng S Lee; Brian M Balgley
Journal:  J Proteome Res       Date:  2008-02-08       Impact factor: 4.466

View more
  23 in total

1.  Downregulation of antigen presentation-associated pathway proteins is linked to poor outcome in triple-negative breast cancer patient tumors.

Authors:  Martin H Pedersen; Brian L Hood; Hans Christian Beck; Thomas P Conrads; Henrik J Ditzel; Rikke Leth-Larsen
Journal:  Oncoimmunology       Date:  2017-03-16       Impact factor: 8.110

2.  Proteomic analysis of formalin-fixed paraffin-embedded pancreatic tissue using liquid chromatography tandem mass spectrometry.

Authors:  Joao A Paulo; Linda S Lee; Peter A Banks; Hanno Steen; Darwin L Conwell
Journal:  Pancreas       Date:  2012-03       Impact factor: 3.327

3.  A quantitative proteomic analysis of FFPE melanoma.

Authors:  Stephanie Byrum; Nathan L Avaritt; Samuel G Mackintosh; Josie M Munkberg; Brian D Badgwell; Wang L Cheung; Alan J Tackett
Journal:  J Cutan Pathol       Date:  2011-08-23       Impact factor: 1.587

4.  Tissue Transglutaminase Mediated Tumor-Stroma Interaction Promotes Pancreatic Cancer Progression.

Authors:  Jiyoon Lee; Salvatore Condello; Bakhtiyor Yakubov; Robert Emerson; Andrea Caperell-Grant; Kiyotaka Hitomi; Jingwu Xie; Daniela Matei
Journal:  Clin Cancer Res       Date:  2015-06-03       Impact factor: 12.531

5.  Inactivation of Ink4a/Arf leads to deregulated expression of miRNAs in K-Ras transgenic mouse model of pancreatic cancer.

Authors:  Shadan Ali; Sanjeev Banerjee; Farah Logna; Bin Bao; Philip A Philip; Murray Korc; Fazlul H Sarkar
Journal:  J Cell Physiol       Date:  2012-10       Impact factor: 6.384

6.  Identification of proteins from 4200-year-old skin and muscle tissue biopsies from ancient Egyptian mummies of the first intermediate period shows evidence of acute inflammation and severe immune response.

Authors:  Jana Jones; Mehdi Mirzaei; Prathiba Ravishankar; Dylan Xavier; Do Seon Lim; Dong Hoon Shin; Raffaella Bianucci; Paul A Haynes
Journal:  Philos Trans A Math Phys Eng Sci       Date:  2016-10-28       Impact factor: 4.226

7.  DMBT1 promotes basal and meconium-induced nitric oxide production in human lung epithelial cells in vitro.

Authors:  Hanna Müller; Christel Weiss; Marcus Renner; Ursula Felderhoff-Müser; Jan Mollenhauer
Journal:  Histochem Cell Biol       Date:  2016-09-15       Impact factor: 4.304

8.  Identification of prosaposin and transgelin as potential biomarkers for gallbladder cancer using quantitative proteomics.

Authors:  Nandini A Sahasrabuddhe; Mustafa A Barbhuiya; Shushruta Bhunia; Tejaswini Subbannayya; Harsha Gowda; Jayshree Advani; Braj R Shrivastav; Sanjay Navani; Pamela Leal; Juan Carlos Roa; Raghothama Chaerkady; Sanjeev Gupta; Aditi Chatterjee; Akhilesh Pandey; Pramod K Tiwari
Journal:  Biochem Biophys Res Commun       Date:  2014-03-20       Impact factor: 3.575

Review 9.  Transglutaminase is a tumor cell and cancer stem cell survival factor.

Authors:  Richard L Eckert; Matthew L Fisher; Dan Grun; Gautam Adhikary; Wen Xu; Candace Kerr
Journal:  Mol Carcinog       Date:  2015-08-10       Impact factor: 4.784

Review 10.  Tissue proteomics in pancreatic cancer study: discovery, emerging technologies, and challenges.

Authors:  Sheng Pan; Teresa A Brentnall; Kimberly Kelly; Ru Chen
Journal:  Proteomics       Date:  2013-01-07       Impact factor: 3.984

View more

北京卡尤迪生物科技股份有限公司 © 2022-2023.